Real-Time Continuous Glucose Monitoring Reduced Costly Diabetes-Related Events in Adolescents and Young Adults despite Lack of Short-Term Reduction in Hemoglobin A1c

Table 1

Participant demographics and clinical characteristics.

Characteristic	Overall	TAU	Intervention
	N = 33^1	N = 13^1	N = 20^1
Gender
Male	17 (51.5%)	6 (46.2%)	11 (55.0%)
Female	16 (48.5%)	7 (53.8%)	9 (45.0%)
Race
White	24 (72.7%)	9 (69.2%)	15 (75.0%)
Black/African American	6 (18.2%)	3 (23.1%)	3 (15.0%)
Native American/American Indian	3 (9.1%)	1 (7.7%)	2 (10.0%)
Ethnicity
Hispanic or latino	9 (27.3%)	4 (30.8%)	5 (25.0%)
Nonhispanic or latino	24 (72.7%)	9 (69.2%)	15 (75.0%)
Insurance status at baseline
Medicaid	21 (63.6%)	10 (76.9%)	11 (55%)
Private	11 (33.3%)	2 (15.4%)	9 (45%)
None	1 (3.0%)	1 (7.7%)	0 (0.0%)
Insulin management
Multiple daily injections	27 (81.8%)	10 (76.9%)	17 (85.0%)
Continuous subcutaneous insulin infusion	6 (18.2%)	3 (23.1%)	3 (15.0%)
Total diabetes-related events at baseline
1	21 (63.6%)	7 (53.8%)	14 (70.0%)
2	5 (15.2%)	3 (23.1%)	2 (10.0%)
3	3 (9.1%)	2 (15.4%)	1 (5.0%)
>3	4 (12.1%)	1 (7.7%)	3 (15.0%)

¹n (%). TAU = treatment as usual.